Literature DB >> 26768861

High-sensitivity C-reactive protein, apolipoproteins, and residual diuresis in chronic kidney disease patients undergoing hemodialysis.

Daniela Lemos Borges1, Helton Pereira Lemes2, Valéria de Castro Ferreira2, Sebastião Rodrigues Ferreira Filho3,4.   

Abstract

BACKGROUND: Residual diuresis (RD) is the simplest method for measuring renal residual function in patients with chronic kidney disease (CKD). A reduction in RD is associated with intensification of the inflammatory process caused by uremia. However, little is known regarding the relation between RD and inflammatory markers in these patients. We verify possible associations among the hs-CRP, atherogenic factors, and RD, in patients with CKD undergoing hemodialysis.
METHODS: This study enrolled 80 patients with CKD undergoing hemodialysis. Patients were stratified according to RD in anuric (RD-) group (n = 47) and non-anuric (RD+) group (n = 33). Urine volumes were collected in a 24 h period during the interdialytic period. Serum high-sensitivity C-reactive protein (hs-CRP), and apolipoprotein (Apo) A1 and B levels were measured after fasting for 12 h.
RESULTS: Serum hs-CRP levels were higher in the RD- group than in the RD+ group (P = 0.015). In the total group, hs-CRP was significantly correlated with RD (r = - 0.25, P = 0.025) and Apo AI (r = - 0.25, P = 0.024). A greater proportion of patients had reduced plasma concentrations of Apo AI in the RD- group (31.9 %) compared with the RD+ group (9.1 %) (P = 0.014).
CONCLUSION: This study shows a relationship between RD and the hs-CRP in patients undergoing hemodialysis. Although the inflammatory state was verified in a large part of the CKD population, patients without RD had more elevated hs-CRP serum levels than those with RD.

Entities:  

Keywords:  Apolipoproteins; Hemodialysis; High-sensitivity C-reactive protein; Residual diuresis

Mesh:

Substances:

Year:  2016        PMID: 26768861     DOI: 10.1007/s10157-016-1230-7

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  36 in total

1.  Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.

Authors:  E Lars Penne; Neelke C van der Weerd; Muriel P C Grooteman; Albert H A Mazairac; Marinus A van den Dorpel; Menso J Nubé; Michiel L Bots; Renée Lévesque; Piet M ter Wee; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients.

Authors:  Chia-Te Liao; Chih-Chung Shiao; Jenq-Wen Huang; Kuan-Yu Hung; Hsueh-Fang Chuang; Yung-Ming Chen; Kwan-Dun Wu; Tun-Jun Tsai
Journal:  Perit Dial Int       Date:  2008-06       Impact factor: 1.756

3.  Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines.

Authors:  Hadja Fatima Tbahriti; Djamel Meknassi; Rachid Moussaoui; Amar Messaoudi; Lakhdar Zemour; Abbou Kaddous; Malika Bouchenak; Khedidja Mekki
Journal:  World J Nephrol       Date:  2013-05-06

Review 4.  Apolipoproteins as markers and managers of coronary risk.

Authors:  D C Chan; G F Watts
Journal:  QJM       Date:  2006-02-27

5.  Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.

Authors:  Hyung-Kwan Kim; Sung-A Chang; Eue-Keun Choi; Yong-Jin Kim; Hyo-Soo Kim; Dae-Won Sohn; Byung-Hee Oh; Myoung-Mook Lee; Young-Bae Park; Yun-Shik Choi
Journal:  Int J Cardiol       Date:  2005-06-08       Impact factor: 4.164

6.  Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.

Authors:  M Chmielewski; J J Carrero; A R Qureshi; J Axelsson; O Heimbürger; L Berglund; P Bárány; B Rutkowski; B Lindholm; P Stenvinkel
Journal:  J Intern Med       Date:  2009-02-27       Impact factor: 8.989

Review 7.  Cardiovascular biology of interleukin-6.

Authors:  Mahinda Y Abeywardena; Wayne R Leifert; Kirsty E Warnes; Jose N Varghese; Richard J Head
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients.

Authors:  Peter Stenvinkel; Peter Barany; Sung Hee Chung; Bengt Lindholm; Olof Heimbürger
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

9.  [Prognostic value of apolipoproteins A and B in the clinical course of patients with chronic kidney disease previous to dialysis].

Authors:  I Cerezo; N Fernández; B Romero; E Fernández-Carbonero; R Hernández-Gallego; F Caravaca
Journal:  Nefrologia       Date:  2009       Impact factor: 2.033

Review 10.  Importance of high-density lipoprotein quality: evidence from chronic kidney disease.

Authors:  Valentina Kon; T Alp Ikizler; Sergio Fazio
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-05       Impact factor: 2.894

View more
  2 in total

1.  Predictors of depression in hemodialysis patients.

Authors:  Tomoyuki Kawada
Journal:  Int Urol Nephrol       Date:  2017-09-26       Impact factor: 2.370

2.  Proteomic Analysis of Human Serum from Patients with Chronic Kidney Disease.

Authors:  Yulia Romanova; Alexander Laikov; Maria Markelova; Rania Khadiullina; Alfiz Makseev; Milausha Hasanova; Albert Rizvanov; Svetlana Khaiboullina; Ilnur Salafutdinov
Journal:  Biomolecules       Date:  2020-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.